(Q51407617)

5 April 2018

meta-analysis

0 references

title

Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis. (English)

1 reference

5 April 2018

0 references

Yuting Wang

1

1 reference

5 April 2018

Chengpeng Zhang

series ordinal

2

1 reference

5 April 2018

Jianjun Liu

series ordinal

3

1 reference

5 April 2018

Gang Huang

series ordinal

4

1 reference

5 April 2018

language of work or name

English

0 references

publication date

30 September 2011

1 reference

5 April 2018

Breast Cancer Research and Treatment

published in

1 reference

5 April 2018

volume

131

1 reference

5 April 2018

issue

2

1 reference

5 April 2018

page(s)

357-369

1 reference

5 April 2018

Primary systemic therapy in operable breast cancer

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Response to therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

The role of PET CT to evaluate the response to neoadjuvant chemotherapy in advanced breast cancer: comparison with ultrasonography and magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Prognostic Impact of [18F] FDG-PET in operable breast cancer treated with neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Early (18)F-2-fluoro-2-deoxy-d-glucose positron emission tomography may identify a subset of patients with estrogen receptor-positive breast cancer who will not respond optimally to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Monitoring primary breast cancer throughout chemotherapy using FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Assessing tumor response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

Preoperative [18F] FDG-PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1780-Z

10.1007/S10549-011-1780-Z

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018